Clinical trial Recruiting at 1 site Interventional Ages 18 to 75

Using royal jelly to reduce inflammation and oxidative stress in people with high blood pressure

Official title: Royal Jelly as a Strategy to Modulate Inflammation and Oxidative Stress in Patients With Systemic Arterial Hypertension

Run by Universidade Federal Fluminense · NCT06917131 · Data updated 2026-11-12

This study is testing if royal jelly can help reduce inflammation and oxidative stress in people with high blood pressure who are already taking medication.

More Hypertension trials

Quick facts

Study typeInterventional
Ages18 Years to 75 Years
SexAll
Enrollment34 (estimated)
SponsorUniversidade Federal Fluminense
Academic / other
Locations1 site (Rio de Janeiro, Rio de Janeiro)
StatusRecruiting
StartedSeptember 18, 2024
Main results expectedDecember 10, 2026
Study endsDecember 10, 2026
Registry record updatedMay 19, 2026
Trial IDNCT06917131 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients with systemic arterial hypertension who are currently on one to three antihypertensive medications and have stable medication doses.

Probably not a fit

Patients with autoimmune diseases, diabetes, chronic kidney disease, liver disease, cancer, or those who are pregnant will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effects of royal jelly on inflammation and oxidative stress in individuals with systemic arterial hypertension. It is designed as a longitudinal double-blind randomized clinical trial lasting two months, involving participants who are already on antihypertensive medications. The research aims to explore the potential of royal jelly, known for its antioxidant and anti-inflammatory properties, as a natural supplement for managing hypertension. The study will compare the effects of royal jelly against a placebo to determine its efficacy in improving health outcomes.

Why it matters

Potential benefit: If successful, this study could provide a natural supplement option for managing hypertension and reducing related health risks.

How similar studies have gone: While there is promising data from in vitro and animal studies regarding royal jelly, clinical studies in human populations are still limited, making this approach relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Diagnosis of stage 1 hypertension
* Regular treatment for more than 6 months
* No changes in medication doses during the last 3 months

Exclusion Criteria:

* Autoimmune diseases
* Infectious diseases
* Diabetes
* Chronic kidney disease
* Liver disease
* Cancer
* AIDS
* Pregnant women
* Use of catabolic drugs or antibiotics
* Use of antioxidant vitamin supplements, prebiotics, probiotics, or synbiotics
* Habitual intake of royal jelly
* Allergy to bee stings
* Acute myocardial infarction (AMI)
* Stroke (CVA)

Where it's running

  • Denise Mafra
    Rio de Janeiro, Rio de Janeiro, Brazil
    Recruiting

Study contacts

  • Principal investigator: Ludmila Cardozo, PhD — Universidade Federal Fluminense
  • Study coordinator: Denise mafra, PhD
  • Email: dmafra30@gmail.com
  • Phone: +5521985683003

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.